|
Market Closed -
Nasdaq
16:00:00 2026-08-25 EDT
|
5-day change | 1st Jan Change | ||
| 84.86 USD | +0.09% |
|
+0.17% | +82.30% |
| Market Cap | 9B 7.71B 7.23B 6.6B 12.46B 858B 12.58B 85.25B 33.19B 433B 33.8B 33.06B 1,434B | P/E 2026 * |
-18.2x | P/E 2027 * | -20.7x |
|---|---|---|---|---|---|
| Enterprise Value | 8B 6.85B 6.42B 5.86B 11.07B 762B 11.18B 75.72B 29.48B 385B 30.02B 29.37B 1,274B | EV / Sales 2026 * |
104x | EV / Sales 2027 * | 46.3x |
| Free-Float |
98.09% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Crinetics Pharmaceuticals, Inc.
| 1 day | +0.09% | ||
| 1 week | +0.17% | ||
| Current month | +1.60% | ||
| 1 month | +1.35% | ||
| 3 months | +130.60% | ||
| 6 months | +95.58% | ||
| Current year | +82.30% |
| 1 week | 84.67 |  | 84.86 |
| 1 month | 83.47 | | 84.86 |
| Current year | 32.3 | | 84.86 |
| 1 year | 30.24 | | 84.86 |
| 3 years | 15.76 | | 84.86 |
| 5 years | 15.23 | | 84.86 |
| 10 years | 10.63 | | 84.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Betz
CTO | Chief Tech/Sci/R&D Officer | 60 | 2021-09-30 |
R. Struthers
CEO | Chief Executive Officer | 64 | 2008-11-30 |
Tobin Schilke
DFI | Director of Finance/CFO | 51 | 2025-02-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Wendell Wierenga
CHM | Chairman | 78 | 2015-09-30 |
R. Struthers
BRD | Director/Board Member | 64 | 2008-10-31 |
Matthew Fust
BRD | Director/Board Member | 61 | 2018-01-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/7/26 | Fiscal year | Founder | 39,856 | 0.0378% | ||
| 7/2/26 | Sell | Director | -3,000 | 0.0028% | ||
| 3/12/26 | Sell | Director | 5,000 | 0.0048% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.09% | +0.17% | +182.02% | +396.84% | 8.99B | |
| +3.31% | -3.70% | +61.03% | +103.64% | 69.06B | |
| +1.74% | +1.06% | +49.02% | +87.38% | 63.06B | |
| +1.09% | +22.96% | +8.55% | -3.03% | 28.34B | |
| -0.07% | -3.56% | -3.45% | +467.26% | 27.07B | |
| -1.72% | +6.58% | +56.50% | +12.82% | 25.45B | |
| +3.98% | +4.37% | +39.47% | -14.65% | 19.69B | |
| +1.02% | +6.43% | +269.42% | +420.34% | 19.19B | |
| -0.19% | -0.57% | +7.19% | +538.65% | 15.95B | |
| +3.98% | +6.78% | +49.66% | +157.94% | 13.52B | |
| Average | +1.24% | +3.79% | +71.94% | +216.72% | 29.03B | |
| Weighted average by Cap. | +1.57% | +2.96% | +59.46% | +164.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 76.86M 65.86M 61.71M 56.37M 106M 7.33B 107M 728M 283M 3.7B 289M 282M 12.24B | 180M 155M 145M 132M 250M 17.2B 252M 1.71B 665M 8.68B 677M 663M 28.74B |
| Net income | -507M -435M -407M -372M -702M -48.38B -709M -4.81B -1.87B -24.41B -1.91B -1.86B -80.83B | -463M -397M -372M -340M -641M -44.18B -648M -4.39B -1.71B -22.29B -1.74B -1.7B -73.82B |
| Net Debt | -1.01B -862M -807M -737M -1.39B -95.85B -1.41B -9.52B -3.71B -48.36B -3.78B -3.69B -160B | -647M -554M -519M -475M -896M -61.68B -904M -6.13B -2.39B -31.12B -2.43B -2.38B -103B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-25 | US$84.86 | +0.09% | 1,241,641 |
| 26-08-24 | US$84.78 | +0.11% | 908,510 |
| 26-08-21 | US$84.69 | 0.00% | 2,016,688 |
| 26-08-20 | US$84.69 | 0.00% | 9,003,934 |
| 26-08-19 | US$84.69 | -0.04% | 2,141,443 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CRNX Stock
Select your edition
All financial news and data tailored to specific country editions
